User profiles for "author:Antonella Ravaggi"
Antonella RavaggiBiologo, Universitą degli Studi di Brescia Verified email at unibs.it Cited by 6411 |
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
Uterine serous carcinoma (USC) is a biologically aggressive subtype of endometrial cancer.
We analyzed the mutational landscape of USC by whole-exome sequencing of 57 cancers …
We analyzed the mutational landscape of USC by whole-exome sequencing of 57 cancers …
[HTML][HTML] Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
E Bignotti, M Ragnoli, L Zanotti, S Calza… - British journal of …, 2011 - nature.com
Background: To date, no good marker for screening or disease monitoring of endometrial
cancer (EC) is available. The aims of this study were to investigate HE4 gene, protein …
cancer (EC) is available. The aims of this study were to investigate HE4 gene, protein …
Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes
AD Santin, PL Hermonat, A Ravaggi, S Bellone… - Journal of …, 2000 - Am Soc Microbiol
Interleukin-10 (IL-10) is widely known as an immunosuppressive cytokine by virtue of its
ability to inhibit macrophage-dependent antigen presentation, T-cell proliferation, and Th1 …
ability to inhibit macrophage-dependent antigen presentation, T-cell proliferation, and Th1 …
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition
Carcinosarcomas (CSs) of the uterus and ovary are highly aggressive neoplasms containing
both carcinomatous and sarcomatous elements. We analyzed the mutational landscape of …
both carcinomatous and sarcomatous elements. We analyzed the mutational landscape of …
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial
AD Santin, S Bellone, M Palmieri, A Zanolini… - Journal of …, 2008 - Am Soc Microbiol
The safety and immunogenicity of the human papillomavirus type 16 (HPV16) or HPV18
(HPV16/18) E7 antigen-pulsed mature dendritic cell (DC) vaccination were evaluated for …
(HPV16/18) E7 antigen-pulsed mature dendritic cell (DC) vaccination were evaluated for …
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management
E Bandiera, C Romani, C Specchia, L Zanotti… - … , biomarkers & prevention, 2011 - AACR
Background: The aim of this work was to analyze the diagnostic and prognostic value of
serum human epididymis protein 4 (HE4) and Risk for Ovarian Malignancy Algorithm …
serum human epididymis protein 4 (HE4) and Risk for Ovarian Malignancy Algorithm …
HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm
G Ruggeri, E Bandiera, L Zanotti, S Belloli… - Clinica Chimica …, 2011 - Elsevier
Background Two commercial immunoassays for HE4 have been compared and the
diagnostic accuracy of HE4, CA 125 and the combinatory ROMA algorithm for epithelial …
diagnostic accuracy of HE4, CA 125 and the combinatory ROMA algorithm for epithelial …
HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study
C Romagnolo, AE Leon, ASC Fabricio, M Taborelli… - Gynecologic …, 2016 - Elsevier
Objective This multicenter study aims to evaluate HE4, CA125 and risk of ovarian
malignancy algorithm (ROMA) performance in the differential diagnosis of epithelial ovarian …
malignancy algorithm (ROMA) performance in the differential diagnosis of epithelial ovarian …
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients
E Bignotti, P Todeschini, S Calza, M Falchetti… - European journal of …, 2010 - Elsevier
BACKGROUND: Prognostic factors currently available are insufficient to predict the clinical
course of epithelial ovarian cancer (EOC). In a previous microarray study we identified the …
course of epithelial ovarian cancer (EOC). In a previous microarray study we identified the …
[HTML][HTML] Prognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancer
E Bandiera, R Franceschini, C Specchia… - International Scholarly …, 2012 - hindawi.com
Introduction. We performed a review of the literature to elucidate the potential prognostic
significance of serum vascular endothelial growth factor (sVEGF) levels in ovarian cancer …
significance of serum vascular endothelial growth factor (sVEGF) levels in ovarian cancer …